Clinical Trial Update: Flt3L in Treating Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating Flt3L in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Flt3L (FLT3 ligand)

Snippet

Sponsor: Duke University | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED